These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 308873)

  • 1. A new animal model for schizophrenia: cholinergic and serotonergic modulation.
    Borison RL; Havdala HS; Diamond BI
    Commun Psychopharmacol; 1978; 2(3):209-14. PubMed ID: 308873
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior.
    Weiner WJ; Goetz C; Westheimer R; Klawans HL
    J Neurol Sci; 1973 Dec; 20(4):373-9. PubMed ID: 4359068
    [No Abstract]   [Full Text] [Related]  

  • 3. Action of serotoninmimetics in the behavioral despair test in rats.
    Górka Z; Wojtasik E; Kwiatek H; Maj J
    Commun Psychopharmacol; 1979; 3(3):133-6. PubMed ID: 315302
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of serotonergic and cholinergic systems in the aggression-stereotypy complex produced by amphetamine in mice.
    Roliński Z
    Pol J Pharmacol Pharm; 1977; 29(6):591-602. PubMed ID: 304574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Yawning elicited by alpha-melanocyte-stimulating hormone involves serotonergic-dopaminergic-cholinergic neuron link in rats.
    Yamada K; Furukawa T
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr; 316(2):155-60. PubMed ID: 6972489
    [No Abstract]   [Full Text] [Related]  

  • 6. The specificity of neuroleptic- and methysergide-induced behavioral hypersensitivity.
    Klawans HL; D'amico DJ; Nausieda PA; Weiner WJ
    Psychopharmacology (Berl); 1977 Nov; 55(1):49-52. PubMed ID: 414261
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic phenylethylamine stereotypy in rats: a new animal model for schizophrenia?
    Borison RL; Havdala HS; Diamond BI
    Life Sci; 1977 Jul; 21(1):117-22. PubMed ID: 560609
    [No Abstract]   [Full Text] [Related]  

  • 8. Serotonin agonist actions of p-chlorophenylalanine.
    Sloviter RS; Drust EG; Connor JD
    Neuropharmacology; 1978 Dec; 17(12):1029-33. PubMed ID: 154622
    [No Abstract]   [Full Text] [Related]  

  • 9. Some 5-hydroxytryptamine-like actions of fenfluramine: a comparison with (+)-amphetamine and diethylpropion.
    Southgate PJ; Mayer SR; Boxall E; Wilson AB
    J Pharm Pharmacol; 1971 Aug; 23(8):600-5. PubMed ID: 4397744
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
    Sahakian BJ; Growdon JH; Millington WR; Barr JK; Wurtman RJ
    Commun Psychopharmacol; 1978; 2(3):255-62. PubMed ID: 568059
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological profile of a model for central serotonin receptor activation.
    Matthews WD; Smith CD
    Life Sci; 1980 Apr; 26(17):1397-403. PubMed ID: 6247593
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonergic and antiserotonergic influences on apomorphine-induced stereotyped behaviour.
    Weiner WJ; Goetz C; Klawans HL
    Acta Pharmacol Toxicol (Copenh); 1975 Feb; 36(2):155-60. PubMed ID: 1079682
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose-response effects of beta-phenylethylamine on stereotyped behavior in pargyline-pretreated rats.
    Moja EA; Stoff DM; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1976 Dec; 11(6):731-42. PubMed ID: 1033771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serotonin both stimulates and inhibits sexual behavior of rats. New possibilities to understand the effects and side-effects of serotonergic drugs].
    Larsson K; Ahlenius S
    Lakartidningen; 1999 Jun; 96(23):2854-6. PubMed ID: 10405533
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
    Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ
    Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of the brain serotoninergic system in the mechanisms of the effect of kyotorphin on animal behavior].
    Semenova TP; Medvinskaia NI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(1):170-2. PubMed ID: 8693783
    [No Abstract]   [Full Text] [Related]  

  • 17. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
    Oelssner W
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():53-60. PubMed ID: 7157125
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral supersensitivity to 5-hydroxytryptophan induced by chronic methysergide pretreatment.
    Klawans HL; D'Amico DJ; Patel BC
    Psychopharmacologia; 1975 Nov; 44(3):297-300. PubMed ID: 1082146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensification of amphetamine-induced excitation by methysergide, a serotonergic receptor blocker.
    Blum K; Wallace JE; Meyer E; Schwertner HA
    Experientia; 1977 Feb; 33(2):213-5. PubMed ID: 844561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.